The GLP-1 receptor agonist exenatide ameliorates neuroinflammation, locomotor activity, and anxiety-like behavior in mice with diet-induced obesity through the modulation of microglial M2 polarization and downregulation of SR-A4.

Saved in:
Bibliographic Details
Title: The GLP-1 receptor agonist exenatide ameliorates neuroinflammation, locomotor activity, and anxiety-like behavior in mice with diet-induced obesity through the modulation of microglial M2 polarization and downregulation of SR-A4.
Authors: Lin, Ming-Hong1,2,3,4 (AUTHOR) mhlin@kmu.edu.tw, Cheng, Po-Ching5,6 (AUTHOR) bonjovi@tmu.edu.tw, Hsiao, Pi-Jung7,8 (AUTHOR) pjhsiao101@isu.edu.tw, Chen, Szu-Chia9,10,11 (AUTHOR) chensc@kmu.edu.tw, Hung, Chih-Hsing11,12,13 (AUTHOR) 1086066@kmuh.org.tw, Kuo, Chao-Hung9,14 (AUTHOR) jhkao@kmu.edu.tw, Huang, Shau-Ku15,16 (AUTHOR) skhuang@nhri.org.tw, Clair Chiou, Hsin-Ying1,17,18,19 (AUTHOR) 1086093@mail.kmuh.org.tw
Source: International Immunopharmacology. Feb2023, Vol. 115, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:15675769
DOI:10.1016/j.intimp.2022.109653